Density-based separation of biological analytes using mutliphase systems

Patent metadata

Field	Value
Publication number	US-10436768-B2
Application number	US-201715825706-A
Country	US
Kind code	B2
Filing date	Nov 29, 2017
Priority date	Aug 20, 2010
Publication date	Oct 8, 2019
Grant date	Oct 8, 2019

Abstract

The disclosed methods use a multi-phase system to separate samples according to the density of an analyte of interest. The method uses a multi-phase system that comprises two or more phase-separated solutions and a phase component such as a surfactant or polymer. The density of the analyte of interest differs from the densities of the rest of the sample. The density of the analyte of interest is substantially the same as one or more phases. Thus, when the sample is introduced to the multi-phase system, the analyte of interest migrates to the phase having the same density as the analyte of interest, passing through one or more phases sequentially.

First claim

What is claimed is:

1. A method of analyzing a sample comprising at least one analyte of interest using a multi-phase system, comprising:
a) providing a sample comprising at least one analyte of interest;
b) providing a multi-phase system comprising two or more phases with clear boundaries, wherein
at least one of the phases comprises a phase component, wherein the phase component is selected from the group consisting of a polymer, a surfactant, and combinations thereof;
each of the two or more phases has a different density and the two or more phases, taken together, represent a density gradient; and
the phases are phase-separated from each other; and
c) introducing the sample comprising a mixture of a tag molecule and the analyte to the multi-phase system, wherein the analyte and the tag molecule form a tag molecule-analyte adduct; and
d) allowing the tag molecule-analyte adduct to migrate to a location in the multiphase system that is characteristic of the adduct's density, wherein during migration the sample contacts one or more of the two or more phases sequentially and the analyte and the tag molecule-analyte adduct occupy different locations.

2. The method of claim 1 , wherein the tag molecule-analyte adduct is formed before or after the sample is introduced to the multi-phase system.

3. The method of claim 1 , wherein the sample comprises one or more biological analytes of interest.

4. The method of claim 1 , wherein the sample comprises one or more non-biological analytes of interest.

5. The method of claim 1 , wherein the multi-phase system comprises one or more biologically compatible phases.

6. The method of claim 1 , wherein the sample comprises the analyte of interest and one or more impurities, the impurity having the same density of the analyte, and the impurity having a different density than the tag molecule-analyte adduct.

7. The method of claim 1 , wherein the analyte of interest has an affinity for the tag molecule, and wherein the analyte of interest and tag molecule preferentially link to form a tag molecule-analyte adduct, the tag molecule-analyte adduct being linked by a method selected from the group consisting of covalent bonding, non-covalent bonding, hybridization, complexation, electrostatic interactions, and conjugation.

8. The method of claim 1 , wherein the tag in the tag molecule-analyte adduct has an affinity for one or more phase components, the tag of the tag molecule-analyte adduct and the phase component preferentially linking such that the tag molecule-analyte adduct preferentially aggregates in one or more phases containing phase components.

9. The method of claim 1 , wherein the analyte of interest is a cell selected from the group consisting of animal, plant, protozoan, and prokaryotic cells.

10. The method of claim 9 , wherein one or more phases cause the cells to lyse, and the biological analyte of interest being recovered from cell lysate.

11. The method of claim 1 , wherein the sample comprises one or more parasites selected from the group consisting of worms, insects, protozoa, arachnids, and arthropods.

12. The method of claim 1 , wherein the sample comprises one or biological carriers selected from the group consisting of whole blood, plasma, serum, sweat, feces, urine, saliva, tears, vaginal fluid, prostatic fluid, gingival fluid, amniotic fluid, intraocular fluid, cerebrospinal fluid, seminal fluid, sputum, ascites fluid, pus, nasopharengal fluid, wound exudate fluid, aqueous humour, vitreous humour, bile, cerumen, endolymph, perilymph, gastric juice, mucus, peritoneal fluid, pleural fluid, sebum, vomit, and combinations thereof.

13. The method of claim 9 , wherein the analyte of interest is separated and analyzed to distinguish cell states selected from the group consisting of normal cells, diseased cells, parasitized cells, cancer cells, foreign cells, and infected cells.

14. The method of claim 1 , wherein the surfactant is selected from the group consisting of polysorbate, CHAPS, polyoxyethylene-polyoxypropylene, 1-O-Octyl-β-D-glucopyranoside, 4-(1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol, 2-(Perfluoroalkyl)ethyl methacrylate, N,N-dimethyldodecylamine N-oxide, polyethylene glycol dodecyl ether, sodium dodecyl sulfate, sodium cholate, nonylphenol polyoxyethylene, benzylalkonium chloride, and dodecyltrimethylammonium chloride.

15. The method of claim 1 , wherein the polymer is selected from the group consisting of dextran, polysucrose, poly(vinyl alcohol), poly(2-ethyl-2-oxazoline), poly(methacrylic acid), poly(ethylene glycol), polyacrylamide, polyethyleneimine, hydroxyethyl cellulose, polyvinylpyrrolidone, carboxy-polyacrylamide, poly(acrylic acid), poly(2-acrylamido-2-methyl-1-propanesulfonic acid), poly(diallyldimethyl ammonium chloride), poly(styrene sulfonic acid), polyallylamine, alginic acid, dextran sulfate, chondroitin sulfate A, diethylaminoethyl-dextran, poly(2-vinylpyridine-N-oxide), polydimethylsiloxane, and poly(propylene glycol).

16. The method of claim 1 , wherein the polymer or surfactant is selected from the group consisting CHAPS, polyoxyethylene-polyoxypropylene, dextran, polysucrose, poly(vinyl alcohol), poly(2-ethyl-2-oxazoline), poly(ethylene glycol), polyacrylamide, hydroxyethyl cellulose, polyvinylpyrrolidone, carboxy-polyacrylamide, dextran sulfate, and poly(2-vinylpyridine-N-oxide).

17. The method of claim 15 , wherein the polymer is a type of polymer selected from the group consisting of a homopolymer, random copolymer, copolymer, terpolymer, block copolymer, linear polymer, branched polymer, random polymer, crosslinked polymer, and dendrimer system.

Assignees

• Harvard College

Inventors

• Mace Charles R
• Kumar Ashok A
• Wirth Dyann F
• Whitesides George M

Classifications

• G01N33/5759

  involving compounds localised on the membrane of tumour or cancer cells · CPC title

• B03D3/00

  Differential sedimentation · CPC title

• G01N33/491 Primary

  by separating the blood components (G01N15/05 takes precedence) · CPC title

• G01N33/18

  Water · CPC title

• B03B5/442

  composition of heavy media · CPC title